Monday, July 23, 2012

Media alert: 24th EORTC - NCI - AACR Symposium 'Molecular Targets and Cancer Therapeutics'

Media alert: 24th EORTC NCI AACR Symposium 'Molecular Targets and Cancer Therapeutics' [ Back to EurekAlert! ] Public release date: 23-Jul-2012
[ | E-mail | Share Share ]

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation

Understanding the pathways and mechanisms that cause cancer and regulate the biological behaviour of tumour cells has led to the development of numerous new agents, 'designer' diagnostics, prognostic tests, 'smart' drugs, innovative targets for clinical trials and other entirely new ways of tackling cancer.

To bring these developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.

At this Symposium, three of the world's leading cancer organisations:

  • The European Organisation for Research and Treatment of Cancer
  • The USA's National Cancer Institute
  • The American Association for Cancer Research
will join forces in Dublin on 6-9 November to provide a platform for presenting recent advances in pre-clinical and clinical research. Around 2,200 international experts in the field will be discussing innovations in drug development, target selection and the impact of new discoveries in molecular biology, while also promoting and developing global partnerships in translational research.

###

We welcome the media to the Symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter on headed paper from the editor of the journal/website they represent stating that they are being commissioned to write a report for publication. Copies of the credentials and identification will be requested at the time of registration and when journalists arrive at the Symposium. Business cards are NOT acceptable.

A media centre with computers, international phone and internet connections will be available.

NB: the official language of the symposium is English and all press materials will be in English.

For media registration, a media registration form can be downloaded at: http://www.ecco-org.eu/Conferences/Conferences/EORTC_NCI_AACR-2012/Media/Media-registration-form.aspx

Please email it to: Riitta.Kettunen@ecco-org.eu
Tel: +32 2 775 02 05
Fax: +32 2 775 02 00

More information on the programme is available on the EORTC-NCI-AACR symposium website at: http://www.ecco-org.eu/

Accommodation

Information on accommodation in Dublin can be found here: http://www.ecco-org.eu/Conferences/Conferences/EORTC_NCI_AACR-2012/Accommodation.aspx

The deadline for hotel reservations is 5 September. After this date, bookings are subject to availability.

Reservations are made on a first-come, first-served basis and participants are advised to book early.



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Media alert: 24th EORTC NCI AACR Symposium 'Molecular Targets and Cancer Therapeutics' [ Back to EurekAlert! ] Public release date: 23-Jul-2012
[ | E-mail | Share Share ]

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation

Understanding the pathways and mechanisms that cause cancer and regulate the biological behaviour of tumour cells has led to the development of numerous new agents, 'designer' diagnostics, prognostic tests, 'smart' drugs, innovative targets for clinical trials and other entirely new ways of tackling cancer.

To bring these developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.

At this Symposium, three of the world's leading cancer organisations:

  • The European Organisation for Research and Treatment of Cancer
  • The USA's National Cancer Institute
  • The American Association for Cancer Research
will join forces in Dublin on 6-9 November to provide a platform for presenting recent advances in pre-clinical and clinical research. Around 2,200 international experts in the field will be discussing innovations in drug development, target selection and the impact of new discoveries in molecular biology, while also promoting and developing global partnerships in translational research.

###

We welcome the media to the Symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter on headed paper from the editor of the journal/website they represent stating that they are being commissioned to write a report for publication. Copies of the credentials and identification will be requested at the time of registration and when journalists arrive at the Symposium. Business cards are NOT acceptable.

A media centre with computers, international phone and internet connections will be available.

NB: the official language of the symposium is English and all press materials will be in English.

For media registration, a media registration form can be downloaded at: http://www.ecco-org.eu/Conferences/Conferences/EORTC_NCI_AACR-2012/Media/Media-registration-form.aspx

Please email it to: Riitta.Kettunen@ecco-org.eu
Tel: +32 2 775 02 05
Fax: +32 2 775 02 00

More information on the programme is available on the EORTC-NCI-AACR symposium website at: http://www.ecco-org.eu/

Accommodation

Information on accommodation in Dublin can be found here: http://www.ecco-org.eu/Conferences/Conferences/EORTC_NCI_AACR-2012/Accommodation.aspx

The deadline for hotel reservations is 5 September. After this date, bookings are subject to availability.

Reservations are made on a first-come, first-served basis and participants are advised to book early.



[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2012-07/eeco-ma2072312.php

dan marino david lee roth joe bodolai ben nelson extreme couponing taylor lautner sinead o connor

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.